Skip to content

Author

V. Rodríguez

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Naringin and hepatic metabolic dysfunction in diabetes and metabolic syndrome: mechanisms and therapeutic perspectives.

Current evidence supports NAR as a promising multitarget therapeutic candidate for hepatic metabolic dysfunction; however, further studies addressing pharmacological optimization and clinical translation are required to fully establish its therapeutic potential.

María Paula Combina Herrera, Gabriela Natalia Ávila Sabattini, G. Picotto et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.